Covishield | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
November 04, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, NOVEMBER 04, 2025

Covishield

Covishield

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo

SII seeks EU travel approval for its Covishield vaccine

Serum's CEO, Adar Poonawalla, said on Monday that his company hopes to "resolve this matter soon", referring to the fact that Covishield had not yet been authorised in the EU

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio

Covishield single dose 61% effective against delta: Indian Covid panel chief

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Serum can supply 6 lakh Covishield to Sri Lanka if purchased for $15 per dose

Balram Bhargava, Director General, ICMR   -  VV Krishnan via The Hindu Business Line

First Covishield jab triggers ‘good levels’ of antibodies

The United States had in February invoked the Defense Production Act, which gives the power to control the distribution of products, to curb the export of raw materials critical for vaccine production.(Representational photo)

No need to worry if one took Covishield jab in 1 or 2-month gap, says Indian govt’s panel member

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Indian govt panel recommends 12-16 week gap between Covishield doses

Doraiswami keen to push Covaxin as Covishield exports disrupted

Doraiswami keen to push Covaxin as Covishield exports disrupted

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio

Covishield price for Indian states reduced from Rs400 to Rs300 per dose

Modi, Biden talk after US says will send raw materials for vaccine

Modi, Biden talk after US says will send raw materials for vaccine

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas

‘Covishield most affordable Covid-19 jab’: SII calls out ‘inaccurate comparison’

A man displays a vial AstraZeneca's COVISHIELD vaccine as the country receives its first batch of coronavirus disease (Covid-19) vaccines under COVAX scheme, in Accra, Ghana February 24, 2021. Photo: Reuters

On Covishield price row, Centre says it will procure vaccines at ₹150 per dose

Bhutanese students in Dhaka during the vaccination. Photo: Kuensel

Bhutanese residing in Bangladesh get vaccines from their country

Hungary approves new Chinese vaccine, and Covishield for emergency use

Hungary approves new Chinese vaccine, and Covishield for emergency use

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net